Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe Abbotsford, British Columbia site entry in the Locations list was added with a slightly different formatting, and the previous Abbotsford listing was removed.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-visible content changes were detected on the study details page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision note added: v3.4.2 replaces v3.4.1. This update does not alter study details or page behavior.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Revision: v3.4.1 and removed the prior government-funding lapse notice (Revision: v3.4.0).SummaryDifference0.1%

- Check67 days agoChange DetectedUI/text updates were added: Show glossary, No FEAR Act Data, and Revision: v3.4.0. The previous labels such as 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4' were removed or updated.SummaryDifference0.1%

Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.